Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Oct;185(4):696-697.
doi: 10.1111/bjd.20513. Epub 2021 Jun 15.

Therapeutic biomarkers in hidradenitis suppurativa: one step closer to the clinic

J W Frew  1   2   3
Affiliations
Comment

Therapeutic biomarkers in hidradenitis suppurativa: one step closer to the clinic

J W Frew. Br J Dermatol. 2021 Oct.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Cao Y, Hong F, Conlon DM et al. Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa. Br J Dermatol 2021; 185:804-14.
    1. Frew JW, Marzano A, Wolk K et al. A systematic review of promising therapeutic targets in hidradenitis suppurativa: a critical evaluation of mechanistic and clinical relevance. J Invest Dermatol 2021; 141:316-24.
    1. Ingram JR, Collier F, Brown D et al. British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018. Br J Dermatol 2019; 180:1009-17.
    1. Navrazhina K, Garcet S, Gonzales J et al. In-depth analysis of the hidradenitis suppurativa serum proteome identifies distinct inflammatory subtypes. J Invest Dermatol 2021; https://doi.org/10.1016/j.jid.2021.02.742.
    1. Frew JW, Jiang CS, Singh N et al. Clinical response rates, placebo response rates, and significantly associated covariates are dependent on choice of outcome measure in hidradenitis suppurativa: a post-hoc analysis of PIONEER 1 and 2 individual patient data. J Am Acad Dermatol 2020; 82:1150-7.